Fingerprint
Dive into the research topics of 'Dual HER2 inhibition in combination with anti-VEGF treatment is active in heavily pretreated HER2-positive breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Dual HER2 inhibition in combination with anti-VEGF treatment is active in heavily pretreated HER2-positive breast cancer
G. S. Falchook, S. L. Moulder, J. J. Wheler, Y. Jiang, C. C. Bastida, R. Kurzrock
Research output: Contribution to journal › Article › peer-review
25
Scopus
citations